Trending...
- OncoBeta Introduces Rhenium-SCT for Non-Melanoma Skin Cancer at Theageneio Cancer Hospital of Thessaloniki
- Arizona Pest Control Surpasses $200,000 in Contributions to Southern Arizona High School Sports and Education Programs
- Spokane: City And County Seek Federal Grant to Plan for Road Network Wildfire Resilience
FAYETTEVILLE, Ark. - Washingtoner -- Lineus Medical is pleased to announce the appointment of Matt Stuckert to its Board of Directors. Stuckert was previously a member of the Lineus Technical Advisory Board. Stuckert brings over a decade of sales leadership experience in the vascular access space, and has held key roles at Magnolia Medical, Becton Dickinson, CareFusion, Cardinal Health, Enturia, and Venetec.. Throughout his career, he has successfully built and led sales teams, and has driven commercial growth, particularly in the adoption of novel new vascular technologies.
His expertise in sales strategy and business development will be instrumental in guiding Lineus Medical's continued success. With a deep understanding of the vascular access market, Stuckert's knowledge will help support the growth of the company's flagship product, SafeBreak Vascular. Stuckert commented, "I am excited to join Lineus Medical's Board of Directors and contribute to the company's growth. SafeBreak Vascular is a game-changing vascular access device that directly addresses IV complications and improves patient experience, both critical issues in hospitals. I look forward to leveraging my experience to help expand SafeBreak's adoption and support the company's mission of improving IV care."
More on Washingtoner
Vance Clement, CEO of Lineus Medical said, "Matt Stuckert's extensive experience in vascular access sales and marketing makes him a valuable addition to our Board. His insights will be instrumental as we expand SafeBreak Vascular's presence in hospitals nationwide. We are excited to have him join our board as we continue to revolutionize what vascular access care looks like."
SafeBreak Vascular is the only break-away device for IV lines clinically proven to reduce IV complications¹. When a harmful force is placed on the line, SafeBreak intentionally separates to remove the damaging force and protect the patient's IV. When SafeBreak separates, valves on both ends of the device close, preventing medicine spills from the pump and blood loss from the patient. To replace SafeBreak, each component is unthreaded from the line, a new sterile SafeBreak is installed, and the patient's infusion is restarted. Patients avoid additional needlesticks, nurses save time, and hospitals save money.1
About Lineus Medical
Lineus Medical is the developer of break-away technology proven to reduce IV restarts and complications¹. Our mission is to remove the pains associated with medical lines. More information about Lineus Medical can be found at www.lineusmed.com. Follow Lineus Medical on LinkedIn.
References:
1. Data on File
His expertise in sales strategy and business development will be instrumental in guiding Lineus Medical's continued success. With a deep understanding of the vascular access market, Stuckert's knowledge will help support the growth of the company's flagship product, SafeBreak Vascular. Stuckert commented, "I am excited to join Lineus Medical's Board of Directors and contribute to the company's growth. SafeBreak Vascular is a game-changing vascular access device that directly addresses IV complications and improves patient experience, both critical issues in hospitals. I look forward to leveraging my experience to help expand SafeBreak's adoption and support the company's mission of improving IV care."
More on Washingtoner
- The World's No.1 Superstar® Brings Christmas Back in Grand Style with Music, Cinematic Glamour, and Luxury Fashion
- New Six-Figure Media Agreement Builds Powerful Momentum, Expanding Government Contracts, FBI Access and Growing AI Recognition: Cyabra (NAS DAQ: CYAB)
- Christmas Beats Summer in Paris: Travel Photoshoots Peak on Dec. 30
- Qscription Technologies Welcomes Joanna Krause, MD, MRMD to Its Clinical Advisory Board
- Jamie Foxx's SKVLK Fest Sets the Record Straight on Stabbing Reports Following Star-Studded Celebration
Vance Clement, CEO of Lineus Medical said, "Matt Stuckert's extensive experience in vascular access sales and marketing makes him a valuable addition to our Board. His insights will be instrumental as we expand SafeBreak Vascular's presence in hospitals nationwide. We are excited to have him join our board as we continue to revolutionize what vascular access care looks like."
SafeBreak Vascular is the only break-away device for IV lines clinically proven to reduce IV complications¹. When a harmful force is placed on the line, SafeBreak intentionally separates to remove the damaging force and protect the patient's IV. When SafeBreak separates, valves on both ends of the device close, preventing medicine spills from the pump and blood loss from the patient. To replace SafeBreak, each component is unthreaded from the line, a new sterile SafeBreak is installed, and the patient's infusion is restarted. Patients avoid additional needlesticks, nurses save time, and hospitals save money.1
About Lineus Medical
Lineus Medical is the developer of break-away technology proven to reduce IV restarts and complications¹. Our mission is to remove the pains associated with medical lines. More information about Lineus Medical can be found at www.lineusmed.com. Follow Lineus Medical on LinkedIn.
References:
1. Data on File
Source: Lineus Medical
Filed Under: Health, Technology
0 Comments
Latest on Washingtoner
- HIRO Ostomy Belt Launch by Richard O'Hamill
- New Omega-3 Fish Oil Under NIH Investigation: What Makes It Different From EPA and DHA?
- Flags Lowered for Spokane County Sheriff Deputies
- Technical Brief Examines Enterprise Integration Challenges as AI Agent Platforms Expand
- ARADIA (Est. 1991) Launches First B2A Partner Program for AI
- OncoBeta Introduces Rhenium-SCT for Non-Melanoma Skin Cancer at Theageneio Cancer Hospital of Thessaloniki
- Spokane: Drugs and Guns Seized in a Counter Narcotics Investigation
- Brian G. Miller Co., LLC Receives Tier 1 Ranking in the 2027 Edition of Best Law Firms®
- The Villari Firm, PLLC Named to the 2027 Edition of Best Law Firms
- Spokane: City and County Issue Joint Housing and Homelessness Funding RFP
- Spokane: Council Approves Additional Funding to Prepare for Inclement Weather
- Bacchus Wine & Spirits and Michelin Guide–Recommended Ethel's Fancy to Host Exclusive LOUIS XIII Limited Edition Diwali Decanter Celebration
- Arizona Pest Control Surpasses $200,000 in Contributions to Southern Arizona High School Sports and Education Programs
- ZenaTech (NAS DAQ: ZENA) $1 Million in New Utility Contracts- Potential $2.5 Million Follow-On Opportunity Puts Its Drone Business in the Spotlight!
- New Patient Data Show REQORSA® Activating Cellular Repair Pathways as Roche Collaboration Advances Precision Lung Cancer Strategy for Genprex, Inc
- Genuine Hospitality, LLC Selected to Operate Holiday Inn Express & Suites Jacksonville – Town Center
- Shiokly Launches Online Marketplace to Help Singapore Home-Based Businesses Sell More, With First Product Listed Free
- Freight Broker 911 and Milton Collier Introduce "What's The 911?"—A New Podcast Built on Real Talk, Real Freight, and Real Opportunity
- PropAccount.com Launches PropWallet, Turning Prop Firm Payouts Into Repeat Sales
- Spokane: City And County Seek Federal Grant to Plan for Road Network Wildfire Resilience


